Concepedia

Sam Dagogo‐Jack

SD

Statistics

Publications

17

Citations

1.4K

H-Index

14

Active since

1986

Affiliations

University of Tennessee Health Science Center(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Harvard University

George Washington University

Pfizer (United States)

Sam Dagogo‐Jack is an author at University of Tennessee Health Science Center specializing in diabetes mellitus, medicine, and endocrinology.

Publications per year

1986–2024

17

Publications

17

American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

Yehuda Handelsman, Robert R. Henry, Zachary T. Bloomgarden et al. · Endocrine Practice · 2016 · 357 citations

, , +12

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease

Francesco Cosentino, Christopher P. Cannon, David Z.I. Cherney et al. · Circulation · 2020 · 241 citations · Full text

, , +17

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

Christopher P. Cannon, Darren K. McGuire, Richard E. Pratley et al. · American Heart Journal · 2018 · 205 citations · Full text

, , +17

Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone

Steven G. Terra, Kristen Focht, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2017 · 145 citations

, , +17

Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program

Leigh Perreault, Yong Ma, Sam Dagogo‐Jack et al. · Diabetes Care · 2008 · 133 citations · Full text

, , +16

1–5 of 17